click for details →
Lastacaft (U.S.N.L.M.)
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dosing | 1 drop daily | |||||||||||
| Chem Specs | alcaftadine 0.25% | |||||||||||
| Quantities | 3 mL | |||||||||||
| Cost | 116.00/3ml | |||||||||||
| Class | H1 receptor antagonist | |||||||||||
| Action | Competitive H1 receptor inhibitor. Mast cell stabilizer.Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated. |
|||||||||||
| Usage | Indicated for the treatment of itching associated with allergic conjunctivitis. | |||||||||||
| BAK may be absorbed in soft contact lenses. Contact lenses may be inserted 10 minutes after administration. Contraindications
| Hypersensitivity to any component of the product.. |
Pediatric use
| Safety and efficacy not established for patients under 2 years of age. |
Pregnancy
| Category B |
| BAK preserved |
Should not be used to treat contact lens-related irritation. |
| |||